313 related articles for article (PubMed ID: 2811008)
1. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
Tsukamura M
Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
[TBL] [Abstract][Full Text] [Related]
2. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine].
Tsukamura M
Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117
[TBL] [Abstract][Full Text] [Related]
3. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
Tsukamura M
Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Tsukamura M; Yamori S
Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of clinical efficacy of rifampicin in the treatment of nontuberculous mycobacteriosis from in vitro susceptibility testing].
Tsukamura M
Kekkaku; 1989 Jul; 64(7):453-8. PubMed ID: 2585946
[TBL] [Abstract][Full Text] [Related]
6. [Differentiation between Mycobacterium malmoense and Mycobacterium nonchromogenicum by ethambutol susceptibility].
Yamori S; Tsukamura M
Kekkaku; 1989 Feb; 64(2):95-7. PubMed ID: 2733305
[TBL] [Abstract][Full Text] [Related]
7. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
Tsukamura M
Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological study of cases with Mycobacterium szulgai infection].
Iwanaga T; Kishikawa R; Ikeda T; Hirose T; Tsurutani H; Yoshida S
Kekkaku; 1998 Oct; 73(10):579-84. PubMed ID: 9844345
[TBL] [Abstract][Full Text] [Related]
10. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility].
Mineshita M; Miyazawa T; Doi M; Suei S; Matsuura M; Senoo T; Yamakido M
Kekkaku; 1993 Jul; 68(7):479-86. PubMed ID: 8361116
[TBL] [Abstract][Full Text] [Related]
11. Current treatment of atypical mycobacteriosis.
Esteban J; Ortiz-Pérez A
Expert Opin Pharmacother; 2009 Dec; 10(17):2787-99. PubMed ID: 19929702
[TBL] [Abstract][Full Text] [Related]
12. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
[TBL] [Abstract][Full Text] [Related]
13. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
Janowiec M; Andrzejczyk Z; Marczewska J
Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y
Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
[TBL] [Abstract][Full Text] [Related]
15. [A case of pulmonary infectious disease due to Mycobacterium szulgai].
Kobashi Y; Okimoto N; Soejima R
Kekkaku; 1999 Oct; 74(10):715-9. PubMed ID: 10565131
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium resistance to antimycobacterial reagent.
Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L
Therapie; 1999; 54(5):623-5. PubMed ID: 10667100
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of Mycobacterium szulgai pulmonary disease in the elderly].
Hamada M; Kajiki A; Nagata N; Wakamatsu K; Komori M; Matsunaga K; Iwata Y; Ishimatsu A; Kitahara Y
Kekkaku; 2005 May; 80(5):427-32. PubMed ID: 16083051
[TBL] [Abstract][Full Text] [Related]
18. [Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii].
Moreno C; Garrigó M; Sánchez F; Coll P
Enferm Infecc Microbiol Clin; 1994 May; 12(5):241-5. PubMed ID: 7811323
[TBL] [Abstract][Full Text] [Related]
19. [Resistance behavior of atypical mycobacteria to antibiotics and sulfonamides].
Neubert R
Z Erkr Atmungsorgane; 1986; 167(1-2):47-51. PubMed ID: 3765715
[TBL] [Abstract][Full Text] [Related]
20. [Nontuberculous mycobacteria and incidence of mycobacterioses in Prague in 1999-2004].
Polanecký V; Kalina P; Kubín M; Kozáková B; Müllerová M
Epidemiol Mikrobiol Imunol; 2006 Nov; 55(4):151-7. PubMed ID: 17354590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
